Clicky

Getting Certified to Administer Esketamine for Treatment-Resistant Depression

Evolving Management Strategies for Treatment-Resistant Depression – Episode 10

May 20, 2021

,

Angelos Halaris, MD, PhD, APA, ACNP, CINP

,

,

Patricia Ares-Romero, MD, FASAM

Requirements that healthcare clinics must satisfy to become a certified treatment center permitted to administer intranasal esketamine to patients with treatment-resistant depression.